Viewing Study NCT06254560


Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2025-12-30 @ 10:09 AM
Study NCT ID: NCT06254560
Status: RECRUITING
Last Update Posted: 2024-02-12
First Post: 2024-01-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module